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ORIGINAL ARTICLE
Treatment of Nodular Fasciitis Occurring on the Face
Byung Ho Oh, Jihee Kim, Zhenlong Zheng, Mi Ryung Roh, Kee Yang Chung
Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea
Background: Surgical excision is generally recommended 
for the treatment of nodular fasciitis (NF) to rule out sarcoma. 
However, in cases of NF occurring on the face, the reported 
recurrence rate is higher and the surgical approach may re-
sult in considerable aesthetic concern. Objective: To de-
scribe our experience with NF occurring on the face and 
evaluate the outcomes of surgical and nonsurgical methods 
of treatment. Methods: We performed a retrospective review 
of 16 patients with NF on the face. The patients were treated 
with surgical excision or nonsurgical methods such as tri-
amcinolone intralesional injection (TA ILI) and pinhole 
method with a carbon dioxide (CO2) laser. Results: Among 
the 16 patients, surgical treatment was performed in 9 and re-
currence occurred in 7 of these 9 patients (77.8%). The re-
curred lesions showed regression after repeated TA ILI. On 
the other hand, five patients underwent nonsurgical treat-
ment after the histologic exclusion of malignancy. Their le-
sions showed regression after repeated pinhole treatment 
and TA ILI. In one case, NF spontaneously regressed. On a 
visual analogue scale, the nonsurgical approach showed su-
perior results. However, the values were not statistically sig-
nificant (6.90±1.56 vs. 5.61±1.36; p=0.163). The sat-
isfaction level was lower in patients who experienced re-
currence after surgical excision. Conclusion: Surgical treat-
ment for NF on the face showed a noticeable recurrence rate 
and resulted in scarring. Therefore, considering the possi-
bility of spontaneous regression, the nonsurgical method can 
be considered as an alternative treatment option for NF on 
the face. (Ann Dermatol 27(6) 694∼701, 2015)
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INTRODUCTION
Nodular fasciitis (NF) is a benign proliferative myofibro-
blastic lesion that may regress spontaneously1. Although 
the etiology of NF is uncertain, histopathologically, it 
bears a close resemblance to organizing granulation tis-
sue, and myofibroblastic proliferation may be initiated by 
a local injury or local inflammatory process, which sup-
ports a reactive proliferation theory triggered by trauma2,3.
NF is frequently mistaken for sarcoma both clinically and 
histopathologically. Therefore, surgical excision is recom-
mended for diagnosis and treatment to exclude malig-
nancy4. However, for lesions occurring on the face, non-
surgical treatment and regular follow-up can be consid-
ered because surgical treatment may cause scarring on the 
face and the lesions may regress spontaneously.
For the nonsurgical treatment of NF on the face, triam-
cinolone intralesional injection (TA ILI) can be used on the 
basis of the fact that NF is a benign reactive or inflam-
matory condition of mesenchymal fibroblasts5. In addi-
tion, considering that early lesions of NF have a myxoid 
pattern of myofibroblast proliferation6, laser treatment can 
be effective in decreasing the size of the lesions through 
tissue contraction. Especially, NF on the face are usually 
‘intradermal type,’ which extends beyond the fascia and 
subcutaneous tissue and invades into the skin, as facial 
muscles such as platysma, frontalis, and orbicularis oculi 
are located superficially underneath the skin7. Therefore, 
such intradermal type of NF can be affected by laser treat-
ment from the skin surface. For example, multiple pin-
holes created by a carbon dioxide (CO2) laser on the skin 
surface can cause tissue contraction, resulting in size re-
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Fig. 1. Nonsurgical treatment with a pinhole method with a CO2
laser.
duction and dermal collagen remodeling8,9.
In this study, the authors retrospectively reviewed cases of 
NF occurring on the face that were treated by using surgi-
cal and nonsurgical methods such as TA ILI and a pinhole 
method with a CO2 laser, and evaluated the outcomes of 
treatment.
MATERIALS AND METHODS
We performed a retrospective review of 16 patients (6 
males, 10 females) with NF on the face clinically and his-
topathologically diagnosed from December 2010 to De-
cember 2013 at Severance Hospital in the Yonsei University 
Health System. Each patient’s details from the medical re-
cord, including age, sex, onset location, trauma history, 
clinical photographs, histopathologic findings, treatment 
methods, clinical progress, and complication profile, were 
fully reviewed. The study protocol was approved by the 
institutional review board of Yonsei University Severance 
Hospital (IRB No. 4-2015-0928) and was conducted ac-
cording to the Declaration of Helsinki Principles.
Histopathologic findings
To evaluate the possibility of nonsurgical treatments, we 
reexamined the histopathologic features. For this review, 
two dermatologists individually reexamined the H&E-stained 
sections, and evaluated the following features in a blind 
manner: depth of the lesion, type of cellular composition, 
and the presence of cellular atypia. Additionally, the pres-
ence of a loose myxoid pattern, which can provide a po-
tential space for injectable agents, was also evaluated. If 
there were atypical cells in the H&E stained section, im-
munohistochemical staining for smooth muscle actin, des-
min, pan-cytokeratin, CD34, S100 protein, and other mark-
ers, was performed to exclude malignancy.
Nonsurgical treatments
The nonsurgical approach was indicated when the diag-
nosis of NF is confirmed and the potential for malignancy 
is excluded with immunohistochemistry in the presence of 
atypical spindle cells. When recurrence occurred after the 
surgical treatment, TA ILI was used after the reevaluation 
of the excised specimen. The pinhole method with CO2 
laser and TA ILI were repeatedly performed simultaneously 
every 4 weeks. Before the treatment, a topical eutectic 
mixture of 2.5% lidocaine and 2.5% prilocaine (EMLA 
cream; AstraZeneca AB, Södertälje, Sweden) was applied 
for local anesthesia. Treatment was performed with an 
output power of 1 to 4 W to make multiple small holes 
approximately 1 to 2 mm in diameter and spaced 2 to 5 
mm apart (Fig. 1). Posttreatment pain was tolerable, and 
erythema spontaneously resolved. Immediately after the 
pinhole treatment, TA ILI was applied to the deep and firm 
part of the NF lesion.
Evaluation of the clinical outcomes
For the evaluation of the clinical outcomes, all photo-
graphic images of NF patients taken 3 months after the fi-
nal treatment were individually evaluated by two derma-
tologists by using a visual analogue scale (VAS). The VAS 
is a 10-cm linear scale in which the left of the scale (score 
of 0) reflects the worst outcome and the right of the scale 
(score of 10) reflects the best outcome. At the end of the 
treatment, patients’ satisfaction was evaluated on a 4-point 
grading scale (0=unsatisfied, 1=slightly satisfied, 2=sat-
isfied, and 3=very satisfied).
Statistical analysis
To compare the outcomes of treatments between the sur-
gical and nonsurgical methods, we performed statistical 
analysis by using the nonparametric Mann-Whitney U 
test, where p-values ≤0.05 were considered statistically 
significant. All data were analyzed by using SPSS 12.0 
(SPSS Inc., Chicago, IL, USA).
RESULTS
The mean age of the 16 patients who had NF on the face 
was 36.6 years (range, 15∼61 years). The average disease 
duration was 3.94 months (range, 3 weeks∼12 months). 
In nine cases (56.3%), patients had histories of physical 
stimulation or trauma, such as facial massage, at least once 
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Table 1. Clinical characteristics and histopathologic features of 16 patients with nodular fasciitis
Case 
no.
Sex
Age 
(yr)
Duration
Trauma 
history
Location Clinical presentation
Main cellular 
component
Depth
Loose 
myxoid 
structure
 1 F 29 3 months Yes Forehead Bean sized skin colored nodule Epithelioid, 
spindle cell
SubQ, 
muscle
Yes
 2 M 58 3 weeks No Zygomatic 
area
Coin sized skin colored deep 
seated nodule
Epithelioid, 
spindle cell*
SubQ, 
muscle
Yes
 3 F 44 10 months Yes Infraorbital Pea sized skin colored nodule Epithelioid, 
spindle cell
SubQ, 
muscle
Yes
 4 F 61 3 months Yes Forehead Bean sized skin colored dome 
shaped nodule
Epithelioid cell SubQ Yes
 5 F 42 1 month Yes Glabella Bean sized skin colored nodule Epithelioid cell SubQ, 
muscle
Yes
 6 F 16 2 months No Postauricular Bean sized erythematous dome 
shaped nodule
Epithelioid cell Dermis, 
subQ 
Yes
 7 M 34 5 months No Infraorbital Match head sized skin colored 
nodule
Spindle cell SubQ, 
muscle
Yes
 8 M 23 2 months No Preauricular Pea sized brown colored 
nodule
Epithelioid cell Dermis, 
subQ
Yes 
(focal)
 9 F 55 1 month Yes Forehead Bean sized brown colored 
nodule
Epithelioid, 
spindle cell
Dermis, 
subQ
Yes 
(focal)
10 F 23 1 year No Postauricular Bean sized erythematous dome 
shaped nodule
Epithelioid, 
spindle cell
Dermis, 
subQ
Yes
11 M 49 6 months Yes Cheek Bean sized skin colored nodule Epithelioid cell* Dermis, 
subQ
Yes
12 F 23 4 months Yes Forehead Bean sized erythematous dome 
shaped nodule
Epithelioid cell* Dermis, 
subQ
Yes
13 M 45 2 months Yes Nose Bean sized brown colored 
nodule
Epithelioid, 
spindle cell*
Dermis, 
subQ, 
muscle
Yes
14 F 15 4 months No Nose Bean sized erythematous dome 
shaped nodule
Epithelioid cell Dermis, 
subQ
Yes
15 M 41 1 month No Nose Pea sized erythematous dome 
shaped nodule
Epithelioid*, 
giant cell
Dermis, 
subQ
Yes
16 F 27 6 months Yes Nose Bean sized erythematous dome 
shaped nodule
Epithelioid cell Dermis, 
subQ
Yes
F: female, M: male, SubQ: subcutaneous fat. Atypical cells were all negative for desmin, pan-cytokeratin, CD34, S100 protein, MART-1,
and positive for smooth muscle actin in immunohistochemical stains.
before the development of NF lesions (Table 1). 
Histopathologic examination showed that NF consisted 
mainly of epithelioid and spindle cells. A loose myxoid 
structure was observed in all cases (Fig. 2). In five cases, a 
few atypical cells were noted in the H&E stain; however, 
they were all negative for desmin, pan-cytokeratin, CD34, 
S100 protein, or MART-1, and positive for smooth muscle 
actin in immunohistochemical stains. All lesions involved 
subcutaneous tissues, whereas seven cases (43.8%) showed 
the involvement of muscle layers, and in 10 cases (62.5%) 
dermal involvement was observed. Among the 16 cases, 
surgical excision was performed in 9 and recurrence de-
veloped in 7 of these 9 cases (77.8%), which were all his-
topathologically confirmed as NF from the excised spe-
cimens. However, the recurred lesions regressed after re-
petitive TA ILI (Fig. 3). In case no. 2, Mohs micrographic 
surgery was performed for the complete removal of the le-
sion because of some atypical cells with mitotic figures in 
the coin-sized lesion and the relatively older age of the pa-
tient (Fig. 4). The pinhole method with a CO2 laser and TA 
ILI, two to three times every 4 weeks, resulted in re-
gression of the five cases of intradermal-type NF (Fig. 5). 
One of the two patients who did not receive any treatment 
showed spontaneous regression after 1 month (Table 2).
The final outcomes were evaluated on the basis of the 
VAS. The mean score of cases no. 12 to 16 who received 
pinhole method treatments (6.90±1.56) was slightly high-
er than that of cases no. 1 to 9 who received surgical ex-
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Fig. 3. Flow chart of the treatment 
outcome. TA ILI: triamcinolone in-
tralesional injection.
Fig. 2. (A) Benign fibroblastic proliferation in subcutaneous areas around facial muscle, which are mostly composed of epithelioid 
and spindle cells (H&E stain, ×40). (B) Loose myxoid structure observed on higher magnification (H&E stain, ×100).
cision (5.61±1.36); however, the difference was not stat-
istically significant (p=0.163). Concerning patients’ sat-
isfaction, the group that received pinhole treatments scor-
ed 1 to 2; however, the group with recurrence after the 
surgical excision scored relatively lower (0∼1) (Table 2). 
Neither the surgically nor the nonsurgically treated group 
reported adverse events such as severe pain or secondary 
infection.
DISCUSSION
Because malignant transformation seldom occurs in be-
nign skin lesions, treatment is not always a requirement as 
long as patients do not mind the cosmetic problems result-
ing from the skin lesions. In cases of NF on the face, pro-
active efforts are needed to perform histopathologic evalu-
ation and treatment because NF tends to grow rapidly on 
the face of adults between the age of 20 and 40 years (i.e., 
persons who are involved in many social activities)10.
Although wide excision is recommended for the treatment 
of NF on the extremities or trunk, it should be reconsid-
ered in facial lesions as it presents several problems in-
cluding scarring. First, surgical excision may not remove 
enough of the area surrounding the lesion because it is dif-
ficult to clearly determine the scope of the lesion because 
inflammation extends to the adjacent muscles and sub-
cutaneous tissues. Particularly, the risk of insufficient ex-
cision can be higher in the face because surgeons try to re-
duce scarring as much as possible. Second, surgical proce-
dures may act as another precipitating factor as NF is a 
myofibroblast proliferation that can be initiated by local 
injury. In this retrospective study, seven of nine patients 
(77.8%) who received surgical excision experienced local 
recurrence, which was a higher rate than those reported 
for other areas of the body10,11. We assume that this result 
may be due to the difficulty in achieving complete surgi-
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Fig. 4. Serial photographs of a representative patient (case no. 2) treated with the surgical approach. (A) A coin-sized, skin-colored, 
deep-seated nodule that recurred on the right zygomatic area. (B) The recurrent lesion was completely removed with Mohs micrographic 
surgery. (C) Reconstruction was done by using a rhombic flap. (D) Surgical treatment eventually resulted in scarring after 3 months.
cal excision in facial lesions or the increased trauma caused 
by surgery. Therefore, when only considering scarring and 
the higher recurrence rate, surgical wide excision is not 
recommended for the first treatment of NF on the face.
Five patients who underwent nonsurgical treatments, such 
as a repeated pinhole treatments and TA ILI, in this study 
showed lesion regression and satisfaction. The prerequisite 
for nonsurgical treatment is a histopathologic confirmation 
to rule out sarcoma. It was reported that fibrosarcoma typi-
cally occurs in patients older than 50 years and in lesions 
＞3 cm12. Although marked cellular atypia is rare in NF le-
sions, cells of fibrosarcoma show more nuclear pleo-
morphism with dense collagenous stroma and without in-
flammatory components. In immunohistochemical stain-
ing, lesional cells of NF can be reactive to vimentin, 
smooth muscle actin, muscle-specific actin, and KP-111. 
For the differential diagnosis, desmin, which is rarely ex-
pressed in NF, may be used to distinguish NF from leio-
myoma and leiomyosarcoma13. In addition, it is possible 
to use CD34 to differentiate NF from dermatofibrosarcoma 
protuberans. However, the Ki67 index, which has been 
documented as useful for the diagnosis and prognosis of 
soft tissue sarcoma14, is not suitable for the assessment of 
NF because of the variation in NF lesions12.
Recently, along with the vast development of laser devices, 
various nonsurgical approaches have been applied in the 
treatment of benign skin tumors. For dermatofibroma (benign 
fibrous histiocytoma), one of the most common benign 
soft tissue tumors, a pulsed dye laser15, fractional laser 
with topical corticosteroid16, or traditional cryotherapy17 
have been applied. As the cells of newly developed NF 
are embedded in a loose myxoid stroma6, intralesional de-
livery of medication can be done successfully. In our 
study, loose myxoid patterns were found in all cases, and 
TA ILI treatment of the lesions resulted in regression. 
However, the effects of intralesional injection may de-
crease for old lesions with increased cellular, fibrous com-
ponents and decreased loose parts, because intralesional 
injection into fibrous and hard lesions is difficult to 
perform.
From our results, a pinhole method with a CO2 laser was 
an effective treatment option for NF on the face, especially 
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Fig. 5. Serial photographs of repre-
sentative patients treated with the 
nonsurgical approach. (A) A bean- 
sized, brown nodule on the nose 
(case no. 13). (B) Three months later, 
after three sessions of pinhole laser 
treatment and triamcinolone intra-
lesional injection (TA ILI). (C) A 
bean-sized, erythematous, dome-sha-
ped nodule on the nose (case no. 
14). (D) Three months later, after 
three sessions of pinhole laser trea-
tment and TA ILI.
those on anatomic locations that may involve significant 
aesthetic concern. CO2 laser treatment may induce tissue 
shrinkage and decrease in the size of NF lesion. The pin-
hole laser treatment has been reported to be an effective 
method in scar management by inducing tissue shrinkage 
and scar remodeling18,19. When it is applied to myxoid le-
sions, its effects may become intensified because the CO2 
laser wavelength is strongly absorbed by water. In addi-
tion, when the pinhole technique is combined with TA ILI, 
inhibition of fibroblast proliferation would also be achieved. 
As the scarring left by this procedure is much smaller than 
the size of the original lesion, scar revision can easily be 
performed, if necessary, after nonsurgical treatments. In 
this retrospective study, the superior cosmetic outcomes of 
the pinhole method resulted in a relatively higher patient 
satisfaction.
Nine of the 16 patients in this study (56.3%) had a history 
of receiving physical stimulation or trauma such as facial 
massages. Although the relation between NF occurrence 
and trauma has not been clearly defined, the possible oc-
currence of NF on the face should be closely monitored as 
persons become more interested in skin care that may 
give physical stimuli to skin. 
Despite the limitation of being a retrospective study with a 
relatively small sample size, we experienced successful 
outcomes with a nonsurgical approach to NF on the face. 
However, potential malignancy should not be overlooked, 
and before any nonsurgical approach, histologic con-
firmation with a sufficiently deep skin biopsy including 
skin and facial muscle parts should be done first. For le-
sions showing recurrence or regrowth with different clin-
ical features from the original lesion, additional skin biop-
sy would be required for further histologic analysis. In 
conclusion, considering the potential aesthetic disfigure-
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Table 2. Treatment outcomes and overall progress of 16 patients with nodular fasciitis
Case no. Treatment and progress
Visual analog scale 
after final treatment
Patients’ 
satisfaction*
 1 Immediate recurrence after excision, regression after 2 session of TA ILI 6.5 1
 2 Recurrence after excision, Mohs micrographic surgery was performed 3.5 1
 3 Recurrence after excision, regression after 2 TA ILI 6.5 0
 4 Recurrence after excision, regression after 2 TA ILI 7.5 1
 5 Recurrence after excision, regression after 2 TA ILI 5.5 1
 6 Recurrence after excision, regression after 1 TA ILI 3.5 0
 7 Recurrence after excision, regression after 1 TA ILI 6.5 1
 8 Excision 5.5 2
 9 Excision 5.5 2
10 None (treatment refused) N/A N/A
11 Spontaneous regression after 1 month N/A N/A
12 Regression after 3 session of CO2 pinhole laser and TA ILI 5.0 1
13 Regression after 3 session of CO2 pinhole laser and TA ILI 8.5 2
14 Regression after 3 session of CO2 pinhole laser and TA ILI 7.5 2
15 Regression after 2 session of CO2 pinhole laser and TA ILI 8.0 2
16 Regression after 3 session of CO2 pinhole laser and TA ILI 5.5 1
TA ILI: triamcinolone intralesional injection, N/A: not applied. *4-point grading scale: 0=unsatisfied, 1=slightly satisfied, 2=satisfied,
3=very satisfied. 
ment and recurrence after conventional wide excision, re-
petitive TA ILI and CO2 pinhole laser can be recom-
mended as a less invasive treatment option. 
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